Back

Doxorubicin-induced upregulation of follistatin-like 3 (FSTL3): a new therapeutic target

29 August 2022 (15:15 - 16:00)
Organised by:
Congress Presentation Part of: Acquired forms of heart failure: cancer and inflammatory disorders Drugs, Drug Targets ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Dongqing Chen

University of Newcastle, Newcastle (Australia)

6 More presentations in this session

Presentation thumbnail
Nuclear accumulation of MLKL induces necroptosis in cardiomyocytes: potential implication in Doxorubicin-induced cardiotoxicity.
Doctor M. Shimizu (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Impact of whole thorax irradiation on cardiac remodeling and outcome after ischemia/reperfusion
Mrs S. Mir (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Extracellular vesicles from the infarcted and failing heart drive tumor growth
Mr T. Caller (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Activation of cardiac macrophages, endothelial cells and fibroblasts in experimental autoimmune myocarditis
Ms K. Tkacz (Cracow, PL)
Abstract Slides
Presentation thumbnail
Dissecting the cardiac cell landscape in myocarditis
Doctor D. Schmidt (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Acquired forms of heart failure: cancer and inflammatory disorders

The Event

Event poster

ESC Congress 2022

29 August 2022 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources